Necrotizing Enterocolitis in Fetuses With Intrauterine Growth Restriction
NCT ID: NCT03869827
Last Updated: 2019-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
378 participants
OBSERVATIONAL
2018-09-01
2019-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors of Necrotizing Enterocolitis in Premature Newborns
NCT04719546
Cohort of Premature Newborns for Charaterization of the Digestive Microbiota in Ulcerative Necrotizing Enterocolitis in Premature Infants
NCT04972734
Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota
NCT06727877
Risk Factors for Poor Prognosis in Neonatal Necrotizing Enterocolitis
NCT07249697
Incidence, Risk Factors, Severity and Prognosis of Necrotizing Enterocolitis in Turkey
NCT04344639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IUGR
All birth between 24 + 0 weeks of amenorrhea and 36 + 6 weeks of amenorrhea with isolated intrauterine growth restriction at the maternity ward of the hospital Femme-Mère-Enfant from 1st of january 2011 to 31 december 2016.
necrotizing enterocolitis
Collection of necrotizing enterocolitis diagnosis, as well as its severity, are based on the classification of Belle modified in 3 stages: 1) Suspected, 2) Proven, 3) Advanced
Control
To each of these children with intrauterine growth restriction is matched a control child: the child without intrauterine growth restriction of the same gestational age whose date of birth is consecutive to that of the case.
necrotizing enterocolitis
Collection of necrotizing enterocolitis diagnosis, as well as its severity, are based on the classification of Belle modified in 3 stages: 1) Suspected, 2) Proven, 3) Advanced
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
necrotizing enterocolitis
Collection of necrotizing enterocolitis diagnosis, as well as its severity, are based on the classification of Belle modified in 3 stages: 1) Suspected, 2) Proven, 3) Advanced
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with isolated intrauterine growth restriction at the maternity ward of the hospital Femme-Mère-Enfant
* from 1st of january 2011 to 31 december 2016.
* All birth between 24 + 0 weeks of amenorrhea and 36 + 6 weeks of amenorrhea
* without isolated intrauterine growth restriction at the maternity ward of the hospital Femme-Mère-Enfant
* from 1st of january 2011 to 31 december 2016.
Exclusion Criteria
* unaccompanied pregnancies
* multiple pregnancies
* children with malformations or genetic abnormalities,
* medical termination of pregnancy
* fetal deaths in utero
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muriel Doret, ¨Prof.
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Femme Mère Enfant
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Muriel Doret, Prof.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECUN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.